Of the 11 patients included in this study, case 8 had mild proptosis, which was not treated with ATD, after GH/IGF-1 levels decreased after TSS and SSA treatment, the symptoms of proptosis improved. This evidence concerns the gene GH1 and Jeune syndrome.